Journal article
BDNF synthesis in spiral ganglion neurons is constitutive and CREB-dependent
Hearing research, Vol.156(1), pp.53-68
2001
DOI: 10.1016/S0378-5955(01)00267-2
PMID: 11377882
Abstract
Brain-derived neurotrophic factor (BDNF), which supports spiral ganglion neuron (SGN) survival in vivo and in vitro, is synthesized by SGNs. The BDNF gene generates multiple different transcripts, each from its own promoter region. Using reverse transcriptase-polymerase chain reaction (RT-PCR), we find that SGNs express only the downstream transcripts III and IV in vivo and in vitro. Using RT-PCR assays of BDNF transcripts and transfection of BDNF promoter–reporter constructs, we tested the hypothesis, originally derived from studies of cortical neurons, that depolarization induces BDNF expression via a signaling pathway that includes Ca
2+/calmodulin-dependent kinases (CaMKs) and the transcription factor, Ca
2+/cyclic AMP response element binding protein (CREB). In contrast, we found that in SGNs in vivo BDNF expression is constitutive and is not increased by electrical activation. Similarly, BDNF expression in vitro is not increased by stimuli that activate CREB, including depolarization, cAMP, or transfection of activated CaMK mutants. However, transfection of dominant-negative CREB mutants did abrogate gene expression driven by BDNF promoters III and IV, indicating that CREB is necessary for constitutive BDNF expression. Thus, BDNF synthesis within SGNs makes possible an autocrine or paracrine mechanism that can contribute to support SGN survival but SGNs are distinctive in that this mechanism is constitutive and not activity-regulated.
Details
- Title: Subtitle
- BDNF synthesis in spiral ganglion neurons is constitutive and CREB-dependent
- Creators
- Xiang-Ming Zha - Departments of Biological Sciences and Otolaryngology, University of Iowa, 138 Biology Building, Iowa City, IA 52242-1324, USAJohn F Bishop - Genetic Pharmacology Unit, Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USAMarlan R Hansen - Departments of Biological Sciences and Otolaryngology, University of Iowa, 138 Biology Building, Iowa City, IA 52242-1324, USALuis Victoria - Departments of Biological Sciences and Otolaryngology, University of Iowa, 138 Biology Building, Iowa City, IA 52242-1324, USAPaul J Abbas - Departments of Speech, Pathology and Otolaryngology, University of Iowa, 138 Biology Building, Iowa City, IA 52242, USAM.Maral Mouradian - Genetic Pharmacology Unit, Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USASteven H Green - Departments of Biological Sciences and Otolaryngology, University of Iowa, 138 Biology Building, Iowa City, IA 52242-1324, USA
- Resource Type
- Journal article
- Publication Details
- Hearing research, Vol.156(1), pp.53-68
- DOI
- 10.1016/S0378-5955(01)00267-2
- PMID
- 11377882
- NLM abbreviation
- Hear Res
- ISSN
- 0378-5955
- eISSN
- 1878-5891
- Publisher
- Elsevier B.V
- Language
- English
- Date published
- 2001
- Academic Unit
- Communication Sciences and Disorders; Molecular Physiology and Biophysics; Biology; Neurosurgery; Otolaryngology
- Record Identifier
- 9984006425502771
Metrics
42 Record Views